Quest Diagnostics (DGX) Treasury Shares (2009 - 2026)

Quest Diagnostics has disclosed Treasury Shares across 18 years of filings, most recently posting $5.2 billion for Q2 2026.

• In Q2 2026, Treasury Shares rose 8.38% year-over-year to $5.2 billion; the TTM figure through Jun 2026 stood at $5.2 billion (up 8.38% YoY), while the FY2025 annual figure was $5.2 billion, up 6.65% from the prior year.
• Treasury Shares came in at $5.2 billion for Q2 2026 at Quest Diagnostics, up from $5.1 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $52.0 million in Q4 2025 to a low of $45.0 million in Q1 2022.
• Average Treasury Shares over 5 years is $49.9 million, with a median of $50.5 million recorded in 2022.
• The largest YoY upside for Treasury Shares was 49.02% in 2022 against a maximum downside of 43.41% in 2022.
• Over 5 years, Treasury Shares stood at $4.7 billion in 2022, then gained by 3.27% to $4.8 billion in 2023, then rose by 0.64% to $4.9 billion in 2024, then grew by 6.65% to $5.2 billion in 2025, then declined by 0.15% to $5.2 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $5.2 billion in Q2 2026, $5.1 billion in Q1 2026, and $5.2 billion in Q4 2025.